GlassScriptPhysician profile
Ian D Archibald
NPI 1447224878
$1,142.31
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $556 · 2020: $488 · 2023: $98.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $98.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $98.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $399.18 | 2019-2023 | |
| Medical Device Business Services, INC. | $197.19 | 2019-2020 | |
| Pacira Therapeutics, INC. | $147.88 | 2019-2020 | |
| Fidia Pharma USA INC. | $137.82 | 2019 | |
| Biocomposites INC | $57.91 | 2020 | |
| Radius Health, INC. | $50.74 | 2019-2020 | |
| Myoscience INC. | $31.63 | 2019 | |
| Ermi LLC | $29.96 | 2019 | |
| Bioventus LLC | $29.83 | 2019 | |
| Kinex Medical Company LLC | $17.72 | 2019 | |
| Convatec INC. | $17.47 | 2019 | |
| Endo Pharmaceuticals INC. | $12.57 | 2019 | |
| Zimmer Biomet Holdings, INC. | $12.41 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Archibald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.